Browse by all authors Browse By Author Name - Krum,+H

Browse Results (35 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Ajani, A., Marwick, T. H. and Krum, H (2006) Aldosterone antagonists: a new treatment option for patients with post-myocardial infarction heart failure. Cardiovascular Revascularization Medicine, 7 4: 234-236. doi:10.1016/j.carrev.2006.07.002 53   Cited 2 times in Scopus2 0
Berakis, A, Williams, TJ, Naughton, MT, Martin, JH, Muhlmann, M and Krum, H (2002) Altered sympathetic and parasympathetic activity in lung transplantation patients at rest and following autonomic perturbation. Chest, 122 4: 1192-1199. doi:10.1378/chest.122.4.1192 34   10 Cited 12 times in Scopus12 0
Haas, S. J., Vos, T., Gilbert, R. and Krum, H. (2003). Are beta-blockers as efficacious in diabetic as non-diabetic patients with chronic heart failure? - Meta-analysis of > 13,000 patients in large-scale clinical trials. In: European Heart Journal: Congress of the European Society of Cardiology. Congress of the European Society of Cardiology, Vienna, Austria, (534-534). 30 Aug - 3 Sep 2003. doi:10.1016/S0195-668X(03)95602-8 94   0 0
Driscoll, A., Davidson, P. M., Hood, S., Huang, N., Aho, Z., Atherton, J., Stewart, S., Sindone, A. and Krum, H. (2009). Best practice for Australian chronic heart failure management programs. In: Cardiac Society of Australia & New Zealand Annual Scientific Meeting, Sydney NSW Australia, (S170-S170). August 2009. doi:10.1016/j.hlc.2009.05.386 22   0
Davidson, P., Driscoll, A., Huang, N., Aho, Z., Atherton, J., Krum, H., Sindone, A. and Stewart, S. (2010). Best practice multidisciplinary care for chronic heart failure in Australia.. In: Australian Disease Management Association: 6th Annual National Disease Management Conference: Chronic disease management and the Australian health system, Melbourme, VIC, Australia, (). 19-20 August 2010. 32  
Huan, N., Aho, Z., Davidson, P., Driscoll, A., Krum, H., Atherton, J., Sindone, A. and Stewart, S. (2011). Best practice multidisciplinary care for chronic heart failure in Australia.. In: Heart Foundation National Conference 2011, Melbourme, VIC, Australia, (). 17-19 March 2011. 39  
Davidson, P., Driscoll, A., Huang, N., Aho, Z., Atherton, J., Hood, S., Krum, H., Sindone, A. and Stewart, S. (2010). Best practice multidisciplinary care for chronic heart failure in Australia. In: Abstracts of the Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. Cardiac Society of Australia & New Zealand Annual Scientific Meeting, Adelaide Australia, (S64-S64). August 2010. doi:10.1016/j.hlc.2010.06.818 33   0
Todd, F., McLean, S., Krum, H., Martin, J. and Copeland, J. (2001). Cannabis. In Management of alcohol and drug problems (pp. 141-157) Adelaide: Oxford University Press. 43  
Kompa, A. R., Thomas, W. G., See, F., Tzanidis, A., Hannan, R. D. and Krum, H. (2004) Cardiovascular Role of Urotensin II: Effect of Chronic Infusion in the Rat. Peptides, 25 10: 1783-1788. doi:10.1016/j.peptides.2004.03.029 42   33 Cited 32 times in Scopus32 0
Krum, H and Stewart, S (2006) Chronic heart failure: time to recognise this major public health problem. Medical Journal Of Australia, 184 4: 147-148. 43   9 Cited 9 times in Scopus9
Pellizzer, A. M., Kamen, P. W., Esler, M. D., Lim, S. and Krum, H. (2001) Comparative effects of mibefradil and nifedipine gastrointestinal transport system on autonomic function in patients with mild to moderate essential hypertension. Journal of Hypertension, 19 2: 279-285. doi:10.1097/00004872-200102000-00015 62   10 Cited 13 times in Scopus13 0
Krum, H, Martin, J, Denver, R and Pepe, S (2004). Direct, dose-dependent antifibrotic effects of atorvastatin in human cardiac fibroblast cell culture. In: Journal of the American College of Cardiology. 54th Annual Scientific Session of the American-College-of-Cardiology, New Orleans La, (160A-160A). Mar 07-10, 2004. doi:10.1016/S0735-1097(04)90679-1 15   0 0
Martin, JH, Denver, R, Pepe, S and Krum, H (2003). Direct, dose-dependent anti-fibrotic effects of atorvastatin in rat and human cardiac fibroblast cell culture. In: European Heart Journal. Congress of the European-Society-of-Cardiology, Vienna Austria, (409-409). Aug 30-Sep 03, 2003. doi:10.1016/S0195-668X(03)95164-5 15   0 0
Tzanidis, A, Lim, S, Hannan, RD and Krum, H (1999) Does endothelin mediate cardiac fibrosis following myocardial infarction via activation of transforming growth factor beta 1?. Circulation, 100 18: 55-55. 50   0
Cantwell, D, Denver, R, Martin, J, Hannan, RD, Way, KJ, Kompa, AR and Krum, H (2004). Does protein kinase CR (PKCP) inhibition directly reduce collagen production from cardiac fibroblasts?. In: Clinical and Experimental Pharmacology and Physiology. 30th International Geographical Congress 2004, Glasgow Scotland, (A3-A3). Aug, 2004. 16   0
Haas, S., Vos, T., Gilbert, R. and Krum, H. (2003). Does the magnitude of the beneficial effect of beta-blockers in chronic heart failure differ between diabetic and nondiabetic patients? A meta-analysis of all-cause mortality outcomes from major chronic heart failure beta-blocker trials. In: Journal of The American College of Cardiology: 52nd Annual Scientific Session of the American College of Cardiology. 52nd Annual Scientific Session of the American College of Cardiology, Chicago, Illinois, (163A-163A). 30- Mar 2 Apr 2003. doi:10.1016/S0735-1097(03)81802-8 203   0 0
Martin, J. H. and Krum, H. (2001) Eplerenone (GD Searle & Co). Current Opinion in Investigational Drugs, 2 4: 521-524. 28   Cited 9 times in Scopus9
Connelly, K. A., Kelly, D. J., Zhang, Y., Prior, D. L., Martin, J., Cox, A. J., Thai, K., Feneley, M. P., Tsoporis, J., White, K. E., Krum, H. and Gilbert, R. E. (2007) Functional, structural and molecular aspects of diastolic heart failure in the diabetic (mRen-2)27 rat. Cardiovascular Research, 76 2: 280-291. doi:10.1016/j.cardiores.2007.06.022 36   37 Cited 37 times in Scopus37 0
White, J, Martin, J, Krum, H., McLean, S, Young, R. M. and Saunders, J. B. (2002). Hallucinogens. In Gary Hulse, Jason White and Gavin Cape (Ed.), Management of Alcohol and Drug Problems First ed. (pp. 229-238) Melbourne: Oxford University Press. 78  
Mcgrady, M., Krum, H., Carrington, M., Stewart, S., Zetiz, C., Lee, G. A., Marwick, T. H., Haluska, B. A. and Brown, A. (2012). Heart failure, ventricular dysfunction and risk factor prevalence in a young Aboriginal population: The Heart of the Heart Study. In: Abstracts of ESC Congress 2012. Congress of the European Society of Cardiology (ESC), Munchen Germany, (161-161). 25-29 August 2012. doi:10.1093/eurheartj/ehs281 21   0 0
Martin, J., Connelly, K., Boyle, A., Kompa, A., Zhang, M., Kelly, D., Gilbert, R. and Krum, H. (2006). Hyperglycemia has a detrimental effect on cardiac remodelling and mortality after myocardial infarction. In: Abstracts for the Cardiac Society of Australia and New Zealand Annual Scientific Meeting. 54th Annual Scientific Meeting of the Cardiac Soc of Australia and New Zealand, Canberra, Australia, (S113-S113). 4-7 August 2006. 21  
Martin, J., Connelly, K., Boyle, A., Kompa, A., Zhang, M., Kelly, D., Gilbert, R. and Krum, H. (2006). Hyperglycemia has a detrimental effect on cardiac remodelling and mortality after myocardial infarction: benefit of statin therapy. In: European Society of Cardiology, World Congress of Cardiology, Barcelona Spain, (522-523). 2-6 September 2006. 36   1
Krum, H., Martin, J. and Gilbert, R. (2007). Interactions between antihypertensive drugs and other medications. In Gregory Y. H. Lip and John E. Hall (Ed.), Comprehensive Hypertension (pp. x-x) New York, USA: Elsevier Health Sciences. 48  
Haas, S. J., Vos, T., Gilbert, R. and Krum, H. (2003). Meta-analysis of effect of beta-blocker therapy on all-cause mortality in diabetic patients with chronic heart failure. In: Clinical and Experimental Pharmacology and Physiology: 24th Annual Scientific Meeting of High Blood Pressure Research Council of Australia Inc. 24th Annual Scientific Meeting of High Blood Pressure Research Council of Australia Inc, Melbourne, Australia, (A61-A62). 25-29 November 2002. 133   0
Whitty J.A., Stewart S., Carrington M.J., Calderone A., Marwick T., Horowitz J.D., Krum H., Davidson P.M., Macdonald P.S., Reid C. and Scuffham P.A. (2013) Patient Preferences and Willingness-To-Pay for a Home or Clinic Based Program of Chronic Heart Failure Management: Findings from the Which? Trial. PLoS ONE, 8 3: e58347.1-e58347.8. doi:10.1371/journal.pone.0058347 41   2 Cited 4 times in Scopus4 0
Krum, H. and Lim, S. (2001) Pharmacoeconomics of beta-blockers: effective and cost-effective therapy in chronic heart failure. European Journal of Heart Failure, 3 4: 399-402. doi:10.1016/S1388-9842(01)00169-6 99   0 Cited 1 times in Scopus1 0
Pellizzer, A.M., Straznicky, N.E., Lim, S., Kamen, P.W. and Krum, H. (1999) Reduced dietary fat intake increases parasympathetic activity in healthy premenopausal women. Clinical And Experimental Pharmacology And Physiology, 26 8: 656-660. doi:10.1046/j.1440-1681.1999.03103.x 105   11 Cited 13 times in Scopus13 0
Martin, J and Krum, H (2002) Role of valsartan and other angiotensin receptor blocking agents in the management of cardiovascular disease. Pharmacological Research, 46 3: 203-212. doi:10.1016/S1043-6618(02)00092-0 28   10 Cited 16 times in Scopus16 0
Haas, S. J., Vos, T. and Krum, H. (2004). Should beta-blockers be used before ACE inhibitors in patients with chronic heart failure? meta-analysis of the prognostic benefit conferred by beta-blockers in patients not receiving ACE inhibitors. In: Clinical And Experimental Pharmacology And Physiology: 30th International Geographical Congress. 30th International Geographical Congress, Glasgow, Scotland, (A8-A9). 15-20 Aug 2004. 229   0
Krum, H. and Martin, J. (2009). Statin therapy in the prevention and treatment of heart failure. In C. W. Yancy and W. H. W. Tang (Ed.), The year in heart failure (pp. 1-129) Oxford, United Kingdom: Clinical Publishing. 66  
Martin, J and Krum, H (2001) The HEART FAILURE Journal Club: a review of publications on heart failure in American Heart Journal. European Journal of Heart Failure, 3 1: 125-137. doi:10.1016/S1388-9842(00)00136-7 25   1 0
Roberts M.A., Pilmore H.L., Ierino F.L., Badve S.V., Cass A., Garg A.X., Hawley C.M., Isbel N.M., Krum H., Pascoe E.M., Tonkin A.M., Vergara L.A. and Perkovic V. (2015) The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study. Nephrology, 20 3: 140-147. doi:10.1111/nep.12362 3   Cited 0 times in Scopus0 0
Martin, JH, Kelly, D, Misfud, S, Zhang, M, Krum, H, Wilkinson-Berka, J and Gilbert, R (2004). Tranilast dose-dependently attenuates extra-cellular matrix deposition in rats.. In: Clinical and Experimental Pharmacology and Physiology. 30th International Geographical Congress 2004, Glasgow Scotland, (A19-A19). Aug, 2004. 23   0
Tzanidis, A., Jun, Y., Lim, S. and Krum, H. (2002). Up-regulation of CTGF following myocardial infarction in the rat and correlation with a1 (I) procollagen and TGF beta 1 gene expression. In: European Heart Journal. XXIV Congress of the European Society of Cardiology, Berlin, Germany, (614-614). 31 Aug - 4 Sept 2002. 51   0
Krum, H, Yao, J, Lim, S and Tzanidis, A (2002) Which factors mediate cardiac fibrosis following myocardial infarction? Role of TGF beta 1 & CTGF in pathological collagen deposition post-MI. Circulation, 106 19: 232-232. 89   0